Clinical Trials
1,037 trialsCHRU-WCMC
University Hospital, Lille
Hemi-Gland Cryoablation for Prostate Cancer at UCLA
Jonsson Comprehensive Cancer Center
Multimodal Machine Learning Characterization of Solid Tumors
Massachusetts General Hospital
Antibiotic Prophylaxis in Percutaneous Nephrostomy Placements and Replacements for Malignant Urinary Tract Obstruction
Barretos Cancer Hospital
KCC-S
University of Utah
Study of Kidney Tumors in Younger Patients
Children's Oncology Group
QUANTIB
IRCCS San Raffaele
Detection of Cancer in Breath Samples by Trained Detection Dogs
SpotitEarly
RF-2018-123683
IRCCS San Raffaele
EXOMAP
IRCCS San Raffaele
MP-PET-MRI
IRCCS San Raffaele
PRS-AS
IRCCS San Raffaele
Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Muscle Invasive Bladder Cancer
Ain Shams University
Breathomics as Predictive Biomarker for Checkpoint Inhibitor Response
University Health Network, Toronto
EVENTIDE
University of Aberdeen
FRISC
Centre Hospitalier Universitaire, Amiens
DRIVE
Pacific Edge Limited
Cause of Familial Testicular Cancer
National Institutes of Health Clinical Center (CC)
Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment
AstraZeneca
PSMA-MRI BX
Fatih Sultan Mehmet Training and Research Hospital
Risk of Scrotal Hydroceles After Nephrectomy For Kidney Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
ZEBRA
Istituto Oncologico Veneto IRCCS
TraveraRTGx
Travera Inc
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
VolUS3D
Assistance Publique - Hôpitaux de Paris
AVENANCE
Pfizer
NOTION: iN-home Sampling Of cyTokines in ImmunOtherapy patieNts
The Christie NHS Foundation Trust
VISIOCYT2
Institut Paoli-Calmettes
KIDCaD
Charles University, Czech Republic
A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients
Novartis
PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.
First Affiliated Hospital of Wenzhou Medical University
Turkish Version of the UCLA Prostate Cancer Index
Lokman Hekim University
A Study of Patient Characteristics, Treatment Patterns and Outcomes Among Patients Treated With 177Lu-PSMA-617
Novartis
GreenBladder - Early Detection of Bladder Cancer in Residents in Greenland Using a Urinary Marker and a Mobile Cystoscopy Unit
Aarhus University Hospital
ADONIS
Pfizer
A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Carcinoma (mRCC).
Pfizer
Biomarkers of AKI in Patients Receiving Daratumumab
Brigham and Women's Hospital
2D:4D Finger Ratio and Breast Cancer in Women
Malatya Turgut Ozal University
Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer
Mayo Clinic
A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer
Pfizer
PROSTED
Centre Hospitalier Universitaire de NÄ«mes
MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research
Yale University
Prospective Validation of Pathology-based Artificial Intelligence Diagnostic Model for Lymph Node Metastasis in Prostate Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients
Institut du Cancer de Montpellier - Val d'Aurelle
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
National Cancer Institute (NCI)
HoSAGE
Assistance Publique Hopitaux De Marseille
Exploring Men s Prostate Cancer Genetic Risk Perceptions
H. Lee Moffitt Cancer Center and Research Institute
Prospective Trial: Acute Myocardial Injury After Radical Prostatectomy
Martini-Klinik am UKE GmbH
Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Pfizer
PRISME
Ipsen